For fiscal 2026 (ended Jun 30, 2026), Cardinal Health Inc. reported $254.25B of revenue and $1.71B of net income.
CAH revenue was $67.51B in fiscal Q1 2027 (ended Sep 30, 2026), up 5.5% from a year earlier. For the full fiscal 2026 it was $254.25B, up 14.2% from fiscal 2025. Compound annual growth was +9.4% over 5 years and +7.7% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.
CAH net income was $554.00M in fiscal Q1 2027 (ended Sep 30, 2026), up 23.1% from a year earlier. For the full fiscal 2026 it was $1.71B, up 9.8% from fiscal 2025. Compound annual growth was +22.9% over 5 years and +1.8% over 10 years. It rose in each of the last 3 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.
CAH diluted EPS was $2.38 in fiscal Q1 2027 (ended Sep 30, 2026), up 26.6% from a year earlier. For the full fiscal 2026 it was $7.23, up 12.1% from fiscal 2025. Compound annual growth was +28.3% over 5 years and +5.3% over 10 years.
CAH free cash flow was $1.24B in fiscal Q1 2027 (ended Sep 30, 2026), up 43.5% from a year earlier. For the full fiscal 2026 it was $4.53B, up 144.6% from fiscal 2025. Compound annual growth was +17.4% over 5 years and +6.1% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B |
| Cost of revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B |
| Gross profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B |
| Selling, general and admin | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.77B |
| Operating income | $2.61B | $2.27B | $1.24B | $752.00M | -$607.00M | $472.00M | -$4.10B | $2.06B | $126.00M | $2.12B |
| Interest expense | $348.00M | $215.00M | $51.00M | $84.00M | $147.00M | $180.00M | $238.00M | $294.00M | $329.00M | $201.00M |
| Pre-tax income | $2.17B | $2.10B | $1.20B | $663.00M | -$784.00M | $323.00M | -$3.77B | $1.75B | -$228.00M | $1.92B |
| Income tax | $469.00M | $532.00M | $348.00M | $332.00M | $153.00M | -$289.00M | -$79.00M | $386.00M | -$487.00M | $630.00M |
| Net income | $1.71B | $1.56B | $852.00M | $330.00M | -$938.00M | $611.00M | -$3.70B | $1.36B | $256.00M | $1.29B |
| EPS, basic | $7.27 | $6.48 | $3.48 | $1.27 | -$3.37 | $2.09 | -$12.61 | $4.55 | $0.82 | $4.06 |
| EPS, diluted | $7.23 | $6.45 | $3.45 | $1.26 | -$3.37 | $2.08 | -$12.61 | $4.53 | $0.81 | $4.03 |
| Diluted shares | 237.0M | 242.0M | 247.0M | 262.0M | 279.0M | 294.0M | 293.0M | 301.0M | 315.0M | 320.0M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.75B | $3.38B | $2.77B | $2.53B | $1.76B | $6.88B |
| Short-term investments | - | - | $200.00M | - | - | - | - | - | - | - |
| Receivables | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B |
| Current assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B |
| Total assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B |
| Current liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.61B | $24.11B | $22.89B | $21.22B |
| Long-term debt | $7.00B | $7.98B | $4.66B | $3.91B | $4.74B | $5.37B | $6.76B | $7.58B | $8.01B | $9.07B |
| Total debt | $7.00B | $7.98B | $4.66B | $3.91B | $4.74B | $5.37B | $6.76B | $7.58B | $8.01B | $9.07B |
| Total liabilities | $60.02B | $55.76B | $48.33B | $46.31B | $44.76B | $42.83B | $38.97B | $34.63B | $33.89B | $33.28B |
| Shareholders' equity | -$2.88B | -$2.63B | -$3.21B | -$2.96B | -$882.00M | $1.62B | $1.79B | $6.33B | $6.06B | $6.83B |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B |
| Capital expenditures | $649.00M | $547.00M | $511.00M | $481.00M | $387.00M | $400.00M | $375.00M | $328.00M | $384.00M | $387.00M |
| Free cash flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.79B | $2.03B | $1.58B | $2.39B | $2.38B | $797.00M |
| Investing cash flow | -$2.58B | -$5.59B | -$1.85B | -$454.00M | $567.00M | -$378.00M | $493.00M | $338.00M | -$5.61B | -$405.00M |
| Financing cash flow | -$1.60B | $1.94B | -$847.00M | -$3.05B | -$2.46B | -$1.32B | -$2.20B | -$2.29B | -$2.28B | $3.75B |
| Dividends paid | $491.00M | $494.00M | $499.00M | $525.00M | $559.00M | $573.00M | $569.00M | $577.00M | $581.00M | $577.00M |
| Share repurchases | $1.36B | $765.00M | $750.00M | $2.00B | $1.00B | $200.00M | $350.00M | $600.00M | $550.00M | $600.00M |
| Stock-based compensation | $367.00M | $244.00M | $121.00M | $96.00M | $81.00M | $89.00M | $90.00M | $82.00M | $85.00M | $96.00M |
| Depreciation and amortization | $956.00M | $790.00M | $710.00M | $692.00M | $692.00M | $783.00M | $913.00M | $1.00B | $1.03B | $717.00M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | 5.1% | 6.4% | 5.3% | 6.9% |
| Net income growth, YoY | 9.8% | 83.2% | 158.2% | - | - | - | - | 432.4% | -80.1% | -9.7% |
| EPS growth, YoY | 12.1% | 87.0% | 173.8% | - | - | - | - | 459.3% | -79.9% | -6.7% |
| Gross margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% |
| Operating margin | 1.0% | 1.0% | 0.5% | 0.4% | -0.3% | 0.3% | -2.7% | 1.4% | 0.1% | 1.6% |
| Net margin | 0.7% | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% | -2.4% | 0.9% | 0.2% | 1.0% |
| Free cash flow margin | 1.8% | 0.8% | 1.4% | 1.2% | 1.5% | 1.2% | 1.0% | 1.6% | 1.7% | 0.6% |
| Return on equity | - | - | - | - | - | 37.6% | -206.3% | 21.5% | 4.2% | 18.9% |
| Return on assets | 3.0% | 2.9% | 1.9% | 0.8% | -2.1% | 1.4% | -9.1% | 3.3% | 0.6% | 3.2% |
| Current ratio | 0.88 | 0.94 | 0.98 | 1.00 | 1.08 | 1.12 | 1.10 | 1.07 | 1.07 | 1.34 |
| Debt to equity | - | - | - | - | - | 3.31 | 3.78 | 1.20 | 1.32 | 1.33 |
| Line item | Sep 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.51B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B | $53.42B |
| Cost of revenue | $64.92B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B | $57.98B | $52.93B | $55.59B | $52.91B | $51.61B |
| Gross profit | $2.60B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B | $1.81B |
| Selling, general and admin | $1.59B | $1.50B | $1.46B | $1.48B | $1.31B | $1.31B | $1.28B | $1.28B | $1.27B | $1.27B | $1.19B | $1.23B |
| Operating income | $753.00M | $707.00M | $668.00M | $428.00M | $730.00M | $549.00M | $568.00M | $401.00M | $369.00M | $505.00M | -$32.00M | $162.00M |
| Interest expense | $73.00M | $88.00M | $80.00M | $74.00M | $74.00M | $35.00M | $32.00M | $9.00M | $28.00M | $3.00M | $11.00M | $6.00M |
| Pre-tax income | $688.00M | $630.00M | $598.00M | $384.00M | $665.00M | $511.00M | $541.00M | $391.00M | $342.00M | $512.00M | -$44.00M | $146.00M |
| Income tax | $132.00M | $159.00M | $144.00M | $141.00M | $157.00M | $110.00M | $124.00M | $158.00M | $80.00M | $143.00M | -$33.00M | $143.00M |
| Net income | $554.00M | $467.00M | $450.00M | $239.00M | $506.00M | $400.00M | $416.00M | $235.00M | $261.00M | $368.00M | -$12.00M | $5.00M |
| EPS, basic | $2.39 | $1.98 | $1.89 | $1.01 | $2.11 | $1.65 | $1.71 | $0.96 | $1.07 | $1.50 | -$0.05 | -$0.22 |
| EPS, diluted | $2.38 | $1.97 | $1.88 | $1.00 | $2.10 | $1.65 | $1.70 | $0.93 | $1.07 | $1.50 | -$0.05 | -$0.21 |
| Diluted shares | 233.0M | 237.0M | 239.0M | - | 241.0M | 243.0M | 245.0M | - | 245.0M | 246.0M | 249.0M | - |
| Line item | Sep 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $5.26B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.75B | $4.60B | $3.87B | $4.08B |
| Short-term investments | - | - | - | - | - | - | - | $200.00M | - | - | - | - |
| Receivables | $14.54B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B | $11.57B | $11.79B | $11.27B | $11.11B |
| Inventory | $18.39B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B | $17.28B | $18.45B | $16.99B | $16.12B |
| Current assets | $40.99B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B | $35.73B | $37.66B | $34.69B | $33.74B |
| Goodwill | $11.54B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B | $4.79B | $4.02B | $4.03B | $4.61B |
| Total assets | $59.54B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | $43.35B |
| Current liabilities | $46.33B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B | $36.31B | $38.29B | $35.06B | $33.74B |
| Long-term debt | $6.93B | $8.35B | $8.98B | $7.98B | $7.14B | $7.06B | $4.22B | $4.66B | $4.67B | $3.54B | $3.89B | $3.91B |
| Total debt | $6.93B | $8.35B | $8.98B | $7.98B | $7.14B | $7.06B | $4.22B | $4.66B | $4.67B | $3.54B | $3.89B | $3.91B |
| Total liabilities | $62.41B | $60.78B | $57.96B | $55.76B | $51.77B | $49.92B | $46.34B | $48.33B | $49.24B | $50.12B | $47.32B | $46.31B |
| Shareholders' equity | -$3.02B | -$2.88B | -$2.73B | -$2.63B | -$2.95B | -$2.92B | -$3.28B | -$3.21B | -$3.36B | -$3.55B | -$3.61B | -$2.96B |
| Line item | Sep 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.40B | $686.00M | $973.00M | $1.53B | $2.91B | -$396.00M | -$1.65B | $2.08B | -$27.00M | $1.18B | $528.00M | $863.00M |
| Capital expenditures | $157.00M | $131.00M | $108.00M | $232.00M | $126.00M | $99.00M | $90.00M | $193.00M | $112.00M | $114.00M | $92.00M | $217.00M |
| Free cash flow | $1.24B | $555.00M | $865.00M | $1.29B | $2.79B | -$495.00M | -$1.74B | $1.89B | -$139.00M | $1.06B | $436.00M | $646.00M |
| Investing cash flow | -$251.00M | -$1.98B | -$142.00M | -$1.63B | -$2.90B | -$976.00M | -$88.00M | $166.00M | -$1.85B | -$105.00M | -$63.00M | -$206.00M |
| Financing cash flow | -$742.00M | -$519.00M | -$110.00M | $656.00M | -$503.00M | $2.33B | -$540.00M | -$859.00M | $1.03B | -$353.00M | -$666.00M | -$592.00M |
| Dividends paid | $126.00M | $122.00M | $129.00M | $120.00M | $124.00M | $122.00M | $128.00M | $122.00M | $122.00M | $124.00M | $131.00M | $126.00M |
| Share repurchases | $500.00M | $383.00M | $375.00M | $0 | $375.00M | $15.00M | $375.00M | $0 | $0 | $250.00M | $500.00M | $500.00M |
| Stock-based compensation | $109.00M | $87.00M | $93.00M | $153.00M | $31.00M | $30.00M | $30.00M | $33.00M | $31.00M | $28.00M | $29.00M | $27.00M |
| Depreciation and amortization | $247.00M | $234.00M | $233.00M | $209.00M | $207.00M | $192.00M | $182.00M | $186.00M | $177.00M | $175.00M | $172.00M | $176.00M |
| Line item | Sep 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 5.5% | 18.8% | 22.4% | 0.5% | 0.0% | -3.8% | -4.3% | 12.1% | 8.7% | 11.6% | 10.2% | 13.5% |
| Net income growth, YoY | 23.1% | 16.8% | 8.2% | 1.7% | 93.9% | 8.7% | - | 4600.0% | -28.5% | - | - | -96.2% |
| EPS growth, YoY | 26.6% | 19.4% | 10.6% | 7.5% | 96.3% | 10.0% | - | - | -24.1% | - | - | - |
| Gross margin | 3.8% | 3.7% | 3.6% | 3.7% | 3.9% | 3.5% | 3.6% | 3.1% | 3.5% | 3.2% | 3.2% | 3.4% |
| Operating margin | 1.1% | 1.1% | 1.0% | 0.7% | 1.3% | 1.0% | 1.1% | 0.7% | 0.7% | 0.9% | -0.1% | 0.3% |
| Net margin | 0.8% | 0.7% | 0.7% | 0.4% | 0.9% | 0.7% | 0.8% | 0.4% | 0.5% | 0.6% | -0.0% | 0.0% |
| Free cash flow margin | 1.8% | 0.8% | 1.4% | 2.2% | 5.1% | -0.9% | -3.3% | 3.2% | -0.3% | 1.9% | 0.8% | 1.2% |
| Current ratio | 0.88 | 0.91 | 0.96 | 0.94 | 0.94 | 1.02 | 0.95 | 0.98 | 0.98 | 0.98 | 0.99 | 1.00 |
Source: XBRL data Cardinal Health Inc. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| CAH | $254.25B | +14.2% | $1.71B | 0.7% | $62.92B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $190.39B |
| MDT | $37.54B | +9.8% | $5.24B | 14.0% | $130.22B |
| MCK | $418.79B | +8.2% | $4.70B | 1.1% | $122.48B |
| BDX | $23.25B | +17.4% | $941.00M | 4.0% | $57.71B |